Add to ORKG© 2015 Nasrallah et al.Introduction: In the present study, we sought to identify markers in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) that distinguish those achieving remission at 6 months following rituximab o
© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for...
associated vasculitis (AAV) is recognized as a chronic, relapsing and potentially fatal disease. Cyc...
Background: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic au...
Objective To evaluate whether the classification of patients with anti-neutrophil cytoplasmic antibo...
Anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) encompasses three disease phen...
OBJECTIVE: To assess clinical and B cell biomarkers to predict relapse after rituximab in antineutro...
ANCA-associated vasculitis (AAV) is a subgrouping of autoimmune disorders characterized by a chronic...
Recent studies have increased our insight into the pathogenesis of ANCA-associated vasculitis (AAV)....
International audienceObjective - To compare long-term efficacy of remission-maintenance regimens in...
The antineutrophil cytoplasmic antibody (ANCA) associated vasculitides (AAV) are a group of primary ...
The antineutrophil cytoplasmic antibody (ANCA) associated vasculitides (AAV) are a group of primary ...
Background: We investigated whether soluble immune checkpoints (sICPs) predict treatment-resistance,...
© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for...
associated vasculitis (AAV) is recognized as a chronic, relapsing and potentially fatal disease. Cyc...
Background: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic au...
Objective To evaluate whether the classification of patients with anti-neutrophil cytoplasmic antibo...
Anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) encompasses three disease phen...
OBJECTIVE: To assess clinical and B cell biomarkers to predict relapse after rituximab in antineutro...
ANCA-associated vasculitis (AAV) is a subgrouping of autoimmune disorders characterized by a chronic...
Recent studies have increased our insight into the pathogenesis of ANCA-associated vasculitis (AAV)....
International audienceObjective - To compare long-term efficacy of remission-maintenance regimens in...
The antineutrophil cytoplasmic antibody (ANCA) associated vasculitides (AAV) are a group of primary ...
The antineutrophil cytoplasmic antibody (ANCA) associated vasculitides (AAV) are a group of primary ...
Background: We investigated whether soluble immune checkpoints (sICPs) predict treatment-resistance,...
© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for...
associated vasculitis (AAV) is recognized as a chronic, relapsing and potentially fatal disease. Cyc...
Background: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic au...